Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Files
Publication date
2024-07-18
Authors
COVID Human Genetic Effort
COVIDeF Study Group
French COVID Cohort Study Group
CoV-Contact Cohort
COVID-STORM Clinicians
COVID Clinicians
Orchestra Working Group
Amsterdam UMC COVID-19 Biobank
NIAID-USUHS COVID Study Group
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Human genetic studies of critical COVID-19 pneumonia have revealed the essential role of type I interferon-dependent innate immunity to SARS-CoV-2 infection. Conversely, an association between the HLA-B∗15:01 allele and asymptomatic SARS-CoV-2 infection in unvaccinated individuals was recently reported, suggesting a contribution of pre-existing T cell-dependent adaptive immunity. We report a lack of association of classical HLA alleles, including HLA-B∗15:01, with pre-omicron asymptomatic SARS-CoV-2 infection in unvaccinated participants in a prospective population-based study in the United States (191 asymptomatic vs. 945 symptomatic COVID-19 cases). Moreover, we found no such association in the international COVID Human Genetic Effort cohort (206 asymptomatic vs. 574 mild or moderate COVID-19 cases and 1,625 severe or critical COVID-19 cases). Finally, in the Human Challenge Characterisation study, the three HLA-B∗15:01 individuals infected with SARS-CoV-2 developed symptoms. As with other acute primary infections studied, no classical HLA alleles favoring an asymptomatic course of SARS-CoV-2 infection were identified.
Keywords
association, asymptomatic infection, COVID-19, HLA, population stratification, Molecular Medicine, Genetics(clinical)
Citation
COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC COVID-19 Biobank & NIAID-USUHS COVID Study Group 2024, 'Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection', Human Genetics and Genomics Advances, vol. 5, no. 3, 100300. https://doi.org/10.1016/j.xhgg.2024.100300